Published in Gene Therapy Weekly, June 29th, 1998
A United Kingdom research group Axis Genetics Plc said development of a new generation of edible vaccines derived from genetically-altered plants had moved a step nearer through an agreement with the U.S.-based Boyce Thompson Institute (BTI) for Plant Research.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.